CYTOKINETICS INC — Director's Dealing 2024

Dec 5, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2024-12-03

Reporting Person: Callos Andrew (EVP, Chief Commercial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-12-03	Common Stock	A	3176	—	Acquired	67063	Direct
2024-12-03	Common Stock	F	1351	$51.51	Disposed	65712	Direct
2024-12-03	Common Stock	A	3177	—	Acquired	68889	Direct

Footnotes

F1: Transaction represents gross shares of common stock received by grantee upon vesting of Performance Stock Units ("PSUs").

F2: Transaction represents withholding of shares to satisfy grantee's tax obligations in connection with vesting PSUs.

F3: Transaction represents shares of PSUs whose performance condition was satisfied but that remain subject to time-based vesting. These PSUs to vest in full December 3, 2025.